Table 1.
Collagen binding peptides | Source | Target | Kd (μM)* | Application | Ref. |
---|---|---|---|---|---|
RRANAALKAGELYKSILYGC | Collagen I platelet receptor | Collagen type I | 0.86 | Modulate collagen fibrillogenesis and inhibit MMP-mediated collagen degradation | 7,8 |
MIVIELGTNPLKSSGIENGAF QGMKK | Leucine-rich repeats (LRR) 4–5 of Decorin | Collagen type I | 0.394 | Induce collagen mineralization in bone defects | 16 |
LRELHLNNN | Inner surface of LRR 10 of Decorin | Collagen type I | 0.17 | Promote controlled release of molecules ≥2 KDa | 18 |
WREPSFCALS | Von Willebrand Factor | Collagen type I | 100 | Promote vascularization and cellularization | 20,21 |
TKKTLRT | Collagenase | Collagen type I | ≤100 | Promote vascularization and cellularization | 21 |
WYRGRL | Phage display | Collagen type II | n.d. | Target articular cartilage | 23–25 |
KLWVLPK | Phage display | Collagen type IV | n.d. | Target sites exposed collagen in blood vessels damaged by balloon angioplasty | 27 |
n.d. = not determined